NEW YORK, July 08, 2013 (eTeligis via ACCESSWIRE) -- IntelliCell BioSciences, Inc. (SVFC), a developer of novel, patented technology used to isolate stromal vascular fraction cells (stem cells) from adipose (fat) tissue. These cells are used to address the regenerative, curative and preventative conditions of disease, announced New York based Maxim Group has issued a research opinion on stem cell sector, and our position within the industry.
Jason Kolbert, the research analyst at Maxim Group commented in his report, IntelliCells position on the legal/regulatory status of SVFC (stromal vascular fraction cells) is that the product is a human cell, tissue, and cellular and tissue-based product (HCT/Ps) and is regulated under the regulations created under 21 C.F.R. 1271. The Company maintains that the SVFC product falls within the exemption from FDA regulation found under 21 C.F.R. 1271.15(b). This is because the HCT/Ps are removed from and reintroduced into the same patient during the same surgical procedure as that term is used in the practice of medicine. The cells that are reintroduced are exactly the same cells (i.e., such cells) as the cells removed from the autologous patient. Thus, the SVFC product falls under an exemption to FDA regulation.
Alternatively, even if the SVFC product is not exempt under 21 C.F.R. 1271.15(b), the company maintains that it meets the requirements in 21 C.F.R. 1271.10(a) for regulation solely under PHS Act 361 and Part 1271 as a 361 HCT/P and not as a drug, device, and/or biologic requiring an approved application. Under that section of the regulation, HCT/Ps that are from an autologous source, minimal manipulation, and for homologous use, and do not include added components (with some minor exceptions) are exempt from FDA pre-approval as a drug.
Under these guidelines IntelliCell Biosciences is empowering clinicians to treat patients today for everything from orthopedic injuries to multiple sclerosis. The company has treated over 300 patients and in some cases with dramatic results. We went so far as to review patients stories and case histories, publications and even met with the companys attorneys (ex-FDA reviewers) to understand the definitions of minimally manipulated and the legal guidelines by which the companys process allows physicians to treat patients. We left believing that this is the only company, at the moment that qualifies with a process that meets current guidelines.
To download the full report from Maxim group please visit http://www.filesanywhere user: Victor07 Password: Anna249249
Register for Mailing List
If you would like to be added to SVFC mailing list, receive updates, or submit a question to the company, please register online at http://www.wallstreetnewscast.com/request/svfc.html
About IntelliCell BioSciences
IntelliCell BioSciences is a Regenerative Medicine company developing novel technologies that address the regenerative, curative and preventative conditions of disease states with high unmet clinical needs. The Company has patented technology for the use of ultrasonic cavitation for separating stromal vascular fraction with stem cells from adipose tissue and several patent-pending. The Company is also pioneering the development of autologous and allogeneic cells from living and non-living tissue donors for research purposes. IntelliCell is planning a series of in-human clinical studies with top tier universities for the treatment of cardiac disease, osteoarthritis, multiple sclerosis, lower limb ischemic wounds, and gum regeneration in the oral cavity as well as medical aesthetics. The Company has developed a first class cGTP cellular processing facility in New York City, purpose built and designed to be fully integrated into an ambulatory surgery center and hospitals. http://www.intellicellbiosciences.com
Forward-Looking Statements
More here:
Maxim Group Issues Stem Cell Sector Report on IntelliCell BioSciences Based on Treatment Process
- Global Stem Cell Reconstructive Market Detailed analysis of current Industry figures with forecasts growth by 2028 | Top Players; Osiris... - January 25th, 2021
- Cell Separation Technologies Market to Reach $28.76 Bn, Globally, by 2027 at 15.4% CAGR, Says Allied Market Research - PRNewswire - January 25th, 2021
- Stem Cell Therapy Market to Witness Increase in Revenues by 2025 NeighborWebSJ - NeighborWebSJ - January 25th, 2021
- Hemostemix Announces the Bread Contract with the Department of Foreign Affairs, Trade & Development Canada - BioSpace - January 23rd, 2021
- Comprehensive Report on Stem Cell Banking Market 2021 | Trends, Growth Demand, Opportunities & Forecast To 2027 |Cordlife, Cryo-Cell... - January 23rd, 2021
- Regenerative Medicine Market Size Worth $23.57 Bn By 2027; High demand for 3D bioprinting of tissues and organs to better understand their mechanism... - January 22nd, 2021
- BrainStorm Announces the Publication of Preclinical Data Highlighting the Potential of a NurOwn Derived Exosome-Based Treatment for COVID-19 ARDS -... - January 22nd, 2021
- Regenerative medicine is advancing health care in diverse ways - Hometown Focus - January 22nd, 2021
- Gene Pathway Linked to Development of Schizophrenia - Psychiatric Times - January 22nd, 2021
- Humanigen Announces the Addition of BARDA and Expansion of CRADA with the US Government to Develop Lenzilumab for COVID-19 - BioSpace - January 22nd, 2021
- Cell Sorting Market Size to Reach USD 805.1 Million By 2027 | Expanding Biotechnology And Pharmaceutical Industries will be the Major Factor Driving... - January 22nd, 2021
- BrainStorm's Covid-19 ARDS treatment improves lung function in study - Clinical Trials Arena - January 22nd, 2021
- Impact of Covid-19 on Automated Cell Culture Market Influencing the Industry Development and Forecast | BD, Tecan Trading, Sartorius, TAP Biosystems,... - January 22nd, 2021
- Global Live Cell Imaging Market Size is Expected to reach USD 3529.26 Million by 2025 and Registeri - PharmiWeb.com - January 22nd, 2021
- [Full text] Identification and Targeting of ThomsenFriedenreich and IL1RAP | OTT - Dove Medical Press - January 22nd, 2021
- New Genetic Disorder Discovered That Affects Brain and Craniofacial Skeleton - Technology Networks - January 22nd, 2021
- Parent Project Muscular Dystrophy Invests $1 Million in Satellos Bioscience to Support New Regenerative Medicine Technology - PRNewswire - January 22nd, 2021
- Stem cells on the ballot - Science Magazine - January 14th, 2021
- 2021 Startups to Watch: Ronawk's T-Blocks stack the future of stem cell research in an Olathe lab - Startland News - January 14th, 2021
- Towards a Cure: Carleton Research Team Working on Stem Cell Therapy to Reverse Type 1 Diabetes - Carleton Newsroom - January 14th, 2021
- Stem Cell Assay Market | Know the aspects that will serve as game-changers for the market - BioSpace - January 14th, 2021
- Center for cell and gene therapy to open next year - Harvard Gazette - January 14th, 2021
- Covid-19 Impact On Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2020 Booming So Rapidly by 2027 | Fibrocell Science, Inc., Genzyme... - January 14th, 2021
- Jasper Therapeutics and Graphite Bio Announce Collaboration to Evaluate JSP191 as Conditioning Regimen for Novel Gene Replacement Therapy in Patients... - January 14th, 2021
- PureTech Founded Entity Vor Announces FDA Clearance of IND Application for VOR33 - Business Wire - January 14th, 2021
- Global Research Antibodies and Reagents Market Report 2020-2027: Significant Opportunities from Emerging Asia-Pacific and Latin-American Markets -... - January 3rd, 2021
- Stem Cell Manufacturing Market Size 2020 Industry Analysis, Key Players, Growth Prospects, Revenue, Production, New Development, Business Share,... - January 3rd, 2021
- Stem Cell Cartilage Regeneration Market : Revenue, Growth, Business Outlook & Forecast 2020-2029 - PharmiWeb.com - January 3rd, 2021
- Global Tissue and Organ Transplantation Market to Surpass US$ 25.6 Billion by 2027, Says Coherent Market Insights (CMI) - Business Wire - January 3rd, 2021
- Viral Clearance Market Is Expected To Reach USD 724.5 Million By 2023 From An Estimated USD 271.2 Million In 2018, At A CAGR Of 21.7% - LionLowdown - December 28th, 2020
- Biobank Market Industry Network, Key Vendors, Growth Analysis, Size, Share, Revenue Strategies and Forecast Report 2020-2026 | Coherent Market... - December 28th, 2020
- Global Neural Stem Cells Market 2020-2026 updated Report with the latest scenarios based on the global COVID-19 Pandemic - Farming Sector - December 24th, 2020
- Organ and Tissue Transplantation and Alternatives - GlobeNewswire - December 24th, 2020
- Comprehensive Report on Animal Stem Cell Therapy Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2027 | ANIMAL CELL THERAPIES,... - December 22nd, 2020
- Canine Stem Cell Therapy Market Analysis, Growth by Top Companies, Trends by Types and Application, Forecast Analysis to 2026 - Factory Gate - December 22nd, 2020
- Adipose Tissue-Derived Stem Cells (ADSCS) Market Size Is Expected To Generate Huge Profits and Competitive Outlook - The Courier - December 22nd, 2020
- Webinar on benefits of 3D cell culture techniques - SelectScience - December 22nd, 2020
- Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients -... - December 22nd, 2020
- The global cell isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9billion in 2020, at a CAGR of 16.8% - GlobeNewswire - December 22nd, 2020
- Orchard Therapeutics Receives EC Approval for Libmeldy for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD) - GlobeNewswire - December 22nd, 2020
- Robert Gallo of the UM School of Medicine Institute of Human Virology and Global Virus Network Awarded Top Life Sciences and Medicine Prize from China... - December 22nd, 2020
- 3D Printing Industry review of the year: February 2020 - 3D Printing Industry - December 22nd, 2020
- Michigans Catholic bishops say 2 COVID-19 vaccines are OK morally but another is problematic - MLive.com - December 21st, 2020
- How Researchers Are Making Do in the Time of COVID-19 - The Wire Science - December 21st, 2020
- Stem cells in drug development - Nordic Life Science - December 19th, 2020
- Global Cell Culture Market by Product, Application, End-user and Region - Forecast to 2025 - PRNewswire - December 19th, 2020
- Glycostem and Ghent University sign license agreement on NK cell therapy technology | DNA RNA and Cells | News Channels - PipelineReview.com - December 19th, 2020
- EdiGene Expands Management Team by Appointment of Head of US Subsidiary Dr. Bo Zhang and Head of Business Development Dr. Kehua Fan - BioSpace - December 19th, 2020
- Global Primary Antibodies Market To Reflect Impressive Growth Rate by 2028||Leading Players-Thermo F - PharmiWeb.com - December 19th, 2020
- US gets more help in raging battle against COVID-19 as FDA authorizes Moderna vaccine, the second allowed for emergency use - USA TODAY - December 19th, 2020
- Diamyd Medical and Critical Path Institute announce data sharing collaboration to develop advanced drug development tools in type 1 diabetes -... - December 19th, 2020
- Skandalaris LEAP winners announced | WashU Fuse | Washington University in St. Louis - Washington University in St. Louis Newsroom - December 19th, 2020
- Creative Medical Technology Holdings Announces Successful Application of ImmCelz Immunotherapy for Treatment of Stroke - PRNewswire - December 17th, 2020
- Glycostem and Ghent University sign license agreement on NK cell therapy technology - PRNewswire - December 17th, 2020
- Creative Medical Technology Stock Price Increased 80.77%: Why It Happened - Pulse 2.0 - December 17th, 2020
- CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV - GlobeNewswire - December 14th, 2020
- EdiGene Expands Management Team by Appointment of Head of US Subsidiary Dr. Bo Zhang and Head of Business Development Dr. Kehua Fan - Business Wire - December 14th, 2020
- 3D Cell Culture Market by Scaffold Format, Products, Application Areas, Purpose, and Key Geographical Regions : Industry Trends and Global Forecasts,... - December 14th, 2020
- Akari Therapeutics Reports Third Quarter 2020 Financial Results and Highlights Recent Clinical Progress - GlobeNewswire - December 14th, 2020
- Researchers identify the origin of a deadly brain cancer - McGill Newsroom - December 14th, 2020
- Insights on the Global Stem Cell Therapy Market 2020-2024: COVID-19 Analysis, Drivers, Restraints, Opportunities, and Threats - Technavio - Yahoo... - December 9th, 2020
- Better education needed to give patients improved understanding of gene therapies, new review highlights - University of Birmingham - December 9th, 2020
- Extended Virus Shedding After COVID in Some Patients With Cancer - Medscape - December 9th, 2020
- Global Cancer Stem Cells Market to Boost with CAGR of 11.8% and Cross a Margin of $1,898.3 Million During the Covid-19 Outbreak Exclusive Report [150... - December 9th, 2020
- City of Hope Doctors Present Innovative Therapies to Better Treat Blood Cancers at American Society of Hematology Virtual Conference - BioSpace - December 9th, 2020
- New DARZALEX (daratumumab) Data from GRIFFIN Study Show Deeper and Longer Responses in Patients with Newly Diagnosed Multiple Myeloma - PRNewswire - December 9th, 2020
- CRISPR Therapeutics and Vertex Present New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001 at American Society of Hematology Annual... - December 9th, 2020
- Genetic engineering transformed stem cells into working mini-livers that extended the life of mice with liver disease - Albany Times Union - December 9th, 2020
- Researchers Trace the Origin of Blood Cancer to Early Childhood, Decades before Diagnosis - PRNewswire - December 9th, 2020
- Stem cells: past, present, and future | Stem Cell Research ... - December 8th, 2020
- Jasper Therapeutics Announces Data from First Transplant-naive Patient in Phase 1 Clinical Trial of JSP191 as Conditioning Agent in Patients with SCID... - December 8th, 2020
- After boosting gene therapy focus, Bayer signs up to new cell therapy pact with Atara - FierceBiotech - December 8th, 2020
- Data published in Cancer Research show Secarna Pharmaceuticals' LNAplus(TM) ASOs targeting metadherin significantly slow progression and metastasis of... - December 8th, 2020
- Europe Tissue Engineering Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Material Type, Applications, and Country -... - December 8th, 2020
- Allogene Therapeutics Presents Preclinical Data on ALLO-316 in Acute Myeloid Leukemia at the 62nd Meeting of the American Society of Hematology -... - December 8th, 2020
- Data Evaluating Tafasitamab with and without Lenalidomide in Combination with R-CHOP in Patients with DLBCL Presented at ASH 2020 - Business Wire - December 8th, 2020
- Incyte Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin... - December 8th, 2020
- Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company... - December 8th, 2020
- Meat-Tech Agrees to Acquire Cultured Fat Pioneer 'Peace of Meat' - PRNewswire - December 8th, 2020
- Actinium Reports 67 Percent Overall Response Rate in First Cohort in Actimab-A Venetoclax Combination Trial in Relapsed and Refractory AML at ASH -... - December 8th, 2020